Cargando…

Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring

BACKGROUND: Continuous glucose monitoring (CGM) uses subcutaneous sensors and records the average interstitial sensor current every 5 min in the recorder; data are subsequently exported to a computer 4 to 7 days later when calibration with self-measured blood glucose is made retrospectively. How mid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Ching-Ju, Chou, Yu-Hsuan, Chen, Yen-Ju, Du, Ye-Fong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403528/
https://www.ncbi.nlm.nih.gov/pubmed/30789351
http://dx.doi.org/10.2196/10992
_version_ 1783400626649038848
author Chiu, Ching-Ju
Chou, Yu-Hsuan
Chen, Yen-Ju
Du, Ye-Fong
author_facet Chiu, Ching-Ju
Chou, Yu-Hsuan
Chen, Yen-Ju
Du, Ye-Fong
author_sort Chiu, Ching-Ju
collection PubMed
description BACKGROUND: Continuous glucose monitoring (CGM) uses subcutaneous sensors and records the average interstitial sensor current every 5 min in the recorder; data are subsequently exported to a computer 4 to 7 days later when calibration with self-measured blood glucose is made retrospectively. How middle-aged and older patients perceive the added technology intervention is not clear. OBJECTIVE: The study aimed to understand the factors associated with the adoption of new technology in diabetes care, to understand the feelings and behaviors while using it, and to determine the changes in attitudes and behavior after completing the use of the new technology at the 3-month follow-up. METHODS: Middle-aged and older type 2 diabetes patients who had received professional continuous glucose monitoring (iPro 2 [Medtronic]) were invited for semistructured in-depth interviews on the day of the CGM sensor removal and at 3 months after CGM-based counseling. A phenomenography approach was used to analyze the interview data. RESULTS: A total of 20 type 2 diabetes patients (aged 53 to 72 years, 13 males and 7 females, 4 to 40 years duration of diabetes, mean glycated hemoglobin 8.54% [SD 0.71%]) completed 2 sections of semistructured in-depth interviews. Physician guidance and participant motivation toward problem solving were found to be factors associated with adoption of the device. Participants indicated that technology can be a reminder, a supervisor, and a visualizer of blood glucose, all of which are helpful for disease management. However, CGM is somewhat inconvenient, and some participants also reported that the provision of this new technology might be a hint of disease progression. There was a higher percentage of women compared with men who reported that CGM can be a reminder or a supervisor to help them with diet control. CONCLUSIONS: Physician guidance and participants’ degree of motivation are keys to adopting new technology in the case of middle-aged and older adults. Although the CGM sensor may cause inconvenience to patients on their limited body movement when wearing the device, it is helpful for diet control and is an effective behavioral modification tool that offers support, especially in the case of women.
format Online
Article
Text
id pubmed-6403528
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-64035282019-03-29 Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring Chiu, Ching-Ju Chou, Yu-Hsuan Chen, Yen-Ju Du, Ye-Fong JMIR Diabetes Original Paper BACKGROUND: Continuous glucose monitoring (CGM) uses subcutaneous sensors and records the average interstitial sensor current every 5 min in the recorder; data are subsequently exported to a computer 4 to 7 days later when calibration with self-measured blood glucose is made retrospectively. How middle-aged and older patients perceive the added technology intervention is not clear. OBJECTIVE: The study aimed to understand the factors associated with the adoption of new technology in diabetes care, to understand the feelings and behaviors while using it, and to determine the changes in attitudes and behavior after completing the use of the new technology at the 3-month follow-up. METHODS: Middle-aged and older type 2 diabetes patients who had received professional continuous glucose monitoring (iPro 2 [Medtronic]) were invited for semistructured in-depth interviews on the day of the CGM sensor removal and at 3 months after CGM-based counseling. A phenomenography approach was used to analyze the interview data. RESULTS: A total of 20 type 2 diabetes patients (aged 53 to 72 years, 13 males and 7 females, 4 to 40 years duration of diabetes, mean glycated hemoglobin 8.54% [SD 0.71%]) completed 2 sections of semistructured in-depth interviews. Physician guidance and participant motivation toward problem solving were found to be factors associated with adoption of the device. Participants indicated that technology can be a reminder, a supervisor, and a visualizer of blood glucose, all of which are helpful for disease management. However, CGM is somewhat inconvenient, and some participants also reported that the provision of this new technology might be a hint of disease progression. There was a higher percentage of women compared with men who reported that CGM can be a reminder or a supervisor to help them with diet control. CONCLUSIONS: Physician guidance and participants’ degree of motivation are keys to adopting new technology in the case of middle-aged and older adults. Although the CGM sensor may cause inconvenience to patients on their limited body movement when wearing the device, it is helpful for diet control and is an effective behavioral modification tool that offers support, especially in the case of women. JMIR Publications 2019-02-21 /pmc/articles/PMC6403528/ /pubmed/30789351 http://dx.doi.org/10.2196/10992 Text en ©Ching-Ju Chiu, Yu-Hsuan Chou, Yen-Ju Chen, Ye-Fong Du. Originally published in JMIR Diabetes (http://diabetes.jmir.org), 21.02.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Diabetes, is properly cited. The complete bibliographic information, a link to the original publication on http://diabetes.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Chiu, Ching-Ju
Chou, Yu-Hsuan
Chen, Yen-Ju
Du, Ye-Fong
Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title_full Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title_fullStr Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title_full_unstemmed Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title_short Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
title_sort impact of new technologies for middle-aged and older patients: in-depth interviews with type 2 diabetes patients using continuous glucose monitoring
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403528/
https://www.ncbi.nlm.nih.gov/pubmed/30789351
http://dx.doi.org/10.2196/10992
work_keys_str_mv AT chiuchingju impactofnewtechnologiesformiddleagedandolderpatientsindepthinterviewswithtype2diabetespatientsusingcontinuousglucosemonitoring
AT chouyuhsuan impactofnewtechnologiesformiddleagedandolderpatientsindepthinterviewswithtype2diabetespatientsusingcontinuousglucosemonitoring
AT chenyenju impactofnewtechnologiesformiddleagedandolderpatientsindepthinterviewswithtype2diabetespatientsusingcontinuousglucosemonitoring
AT duyefong impactofnewtechnologiesformiddleagedandolderpatientsindepthinterviewswithtype2diabetespatientsusingcontinuousglucosemonitoring